-
$2,000 Read More Botulism – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Botulism - Pipeline Review, H1 2016’, provides an overview of the Botulism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Botulism, complete with analysis by stage of development, drug target, mechanism of acti... -
$2,000 Read More Cholera – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Cholera - Pipeline Review, H1 2016’, provides an overview of the Cholera pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cholera, complete with analysis by stage of development, drug target, mechanism of action ... -
$2,000 Read More Typhoid Fever – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H1 2016’, provides an overview of the Typhoid Fever pipeline landscape. The report provides comprehensive information on the therapeutics under development for Typhoid Fever, complete with analysis by stage of development, drug target, me... -
$2,000 Read More Lyme Disease – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Lyme Disease - Pipeline Review, H1 2016’, provides an overview of the Lyme Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lyme Disease, complete with analysis by stage of development, drug target, mecha... -
$2,000 Read More Bacterial Vaginosis – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Bacterial Vaginosis - Pipeline Review, H1 2016’, provides an overview of the Bacterial Vaginosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bacterial Vaginosis, complete with analysis by stage of developmen... -
$2,000 Read More Ragweed Allergy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Ragweed Allergy - Pipeline Review, H1 2016’, provides an overview of the Ragweed Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ragweed Allergy, complete with analysis by stage of development, drug targ... -
$2,000 Read More Birch Pollen Allergy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Birch Pollen Allergy - Pipeline Review, H1 2016’, provides an overview of the Birch Pollen Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Birch Pollen Allergy, complete with analysis by stage of develop... -
Read More Diabetic Neuropathic Pain – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape. The report provides comprehensive information on the therapeutics under development for Diabetic Neuropathic Pain, complete with analysis by s... -
$2,000 Read More House Dust Mite Allergy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘House Dust Mite Allergy - Pipeline Review, H1 2016’, provides an overview of the House Dust Mite Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for House Dust Mite Allergy, complete with analysis by stage o... -
$2,000 Read More Iron Deficiency Anemia – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Iron Deficiency Anemia - Pipeline Review, H1 2016’, provides an overview of the Iron Deficiency Anemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Iron Deficiency Anemia, complete with analysis by stage of d...
Sorry, there is no ad related to this category!
-
$2,000 Read More Atrial Fibrillation – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Atrial Fibrillation – Pipeline Review, H1 2016’, provides an overview of the […]
-
$2,995 Read More Evolving Market Access Strategies – Pricing and Reimbursement Landscape in...
GBI Research’s latest report, “Evolving Market Access Strategies – Pricing and Reimbursement Landscape in Major […]
-
$2,000 Read More Renal Insufficiency – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Renal Insufficiency – Pipeline Review, H1 2016’, provides an overview of the […]
-
$2,000 Read More Hospital Acquired Pneumonia (HAP) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Hospital Acquired Pneumonia (HAP) – Pipeline Review, H1 2016’, provides an overview […]
-
$4,995 Read More Global Immunology Market to 2022 – Large pipeline and competitive market t...
Immune-mediated inflammatory diseases are a very common set of chronic disorders that affect 5–7% of […]
-
$1,500 Read More Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceut...
GlobalData’s “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2015” report […]
-
$2,000 Read More Streptococcus pyogenes Infections – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Streptococcus pyogenes Infections – Pipeline Review, H1 2016’, provides an overview of […]
-
$2,500 Read More Genital Herpes Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Genital Herpes. Report […]
-
$4,995 Read More Type 2 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 –...
Type 2 Diabetes Mellitus (T2DM) is a metabolic disease characterized by chronic hyperglycemia (high blood […]
-
$2,000 Read More Hidradenitis Suppurativa – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Hidradenitis Suppurativa – Pipeline Review, H1 2016’, provides an overview of the […]
